Design and Synthesis of Multi-Functional Ligands through Hantzsch Reaction: Targeting Ca2+ Channels, Activating Nrf2 and Possessing Cathepsin S Inhibitory, and Antioxidant Properties

This work relates to the design and synthesis of a series of novel multi-target directed ligands (MTDLs), i.e., compounds 4a–l, via a convenient one-pot three-component Hantzsch reaction. This approach targeted calcium channel antagonism, antioxidant capacity, cathepsin S inhibition, and interferenc...

Full description

Saved in:
Bibliographic Details
Published in:Pharmaceutics 2024-01, Vol.16 (1), p.121
Main Authors: Pachón-Angona, Irene, Bernard, Paul J., Simakov, Alexey, Maj, Maciej, Jozwiak, Krzysztof, Novotna, Anna, Lemke, Carina, Gütschow, Michael, Martin, Helene, Oset-Gasque, María-Jesús, Contelles, José-Marco, Ismaili, Lhassane
Format: Article
Language:English
Subjects:
Alzheimer’s disease
antioxidant response element
Antioxidants
calcium channel inhibitors
Chromatography
Dioxins
Disease
Kinases
Ligands
Older people
ORAC
Pathogenesis
Pathology
Peptides
proteases inhibitors
Proteins
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This work relates to the design and synthesis of a series of novel multi-target directed ligands (MTDLs), i.e., compounds 4a–l, via a convenient one-pot three-component Hantzsch reaction. This approach targeted calcium channel antagonism, antioxidant capacity, cathepsin S inhibition, and interference with Nrf2 transcriptional activation. Of these MTDLs, 4i emerged as a promising compound, demonstrating robust antioxidant activity, the ability to activate Nrf2-ARE pathways, as well as calcium channel blockade and cathepsin S inhibition. Dihydropyridine 4i represents the first example of an MTDL that combines these biological activities.
ISSN:1999-4923
1999-4923
DOI:10.3390/pharmaceutics16010121